To include your compound in the COVID-19 Resource Center, submit it here.
CAP2, a second Phase III study with the same protocol as CAP1, is ongoing in the Southern Hemisphere. Regulatory
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury